Sökning: onr:"swepub:oai:DiVA.org:uu-272054" >
Diagnostic value of...
-
Adamczuk, KatarzynaKatholieke Univ Leuven, Lab Cognit Neurol, B-3000 Louvain, Belgium.;Katholieke Univ Leuven, Leuven Inst Neurosci & Dis, Alzheimer Res Ctr, B-3000 Louvain, Belgium.
(författare)
Diagnostic value of cerebrospinal fluid A beta ratios in preclinical Alzheimer's disease
- Artikel/kapitelEngelska2015
Förlag, utgivningsår, omfång ...
-
2015-12-18
-
Springer Science and Business Media LLC,2015
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-272054
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-272054URI
-
https://doi.org/10.1186/s13195-015-0159-5DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Introduction: In this study of preclinical Alzheimer's disease (AD) we assessed the added diagnostic value of using cerebrospinal fluid (CSF) A beta ratios rather than A beta 42 in isolation for detecting individuals who are positive on amyloid positron emission tomography (PET). Methods: Thirty-eight community-recruited cognitively intact older adults (mean age 73, range 65-80 years) underwent F-18-flutemetamol PET and CSF measurement of A beta 1-42, A beta 1-40, A beta 1-38, and total tau (ttau). F-18-flutemetamol retention was quantified using standardized uptake value ratios in a composite cortical region (SUVRcomp) with reference to cerebellar grey matter. Based on a prior autopsy validation study, the SUVRcomp cut-off was 1.57. Sensitivities, specificities and cut-offs were defined based on receiver operating characteristic analysis with CSF analytes as variables of interest and F-18-flutemetamol positivity as the classifier. We also determined sensitivities and CSF cut-off values at fixed specificities of 90 % and 95 %. Results: Seven out of 38 subjects (18 %) were positive on amyloid PET. A beta 42/ttau, A beta 42/A beta 40, A beta 42/A beta 38, and A beta 42 had the highest accuracy to identify amyloid-positive subjects (area under the curve (AUC) >= 0.908). A beta 40 and A beta 38 had significantly lower discriminative power (AUC = 0.571). When specificity was fixed at 90 % and 95 %, A beta 42/ttau had the highest sensitivity among the different CSF markers (85.71 % and 71.43 %, respectively). Sensitivity of A beta 42 alone was significantly lower under these conditions (57.14 % and 42.86 %, respectively). Conclusion: For the CSF-based definition of preclinical AD, if a high specificity is required, our data support the use of A beta 42/ttau rather than using A beta 42 in isolation.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Schaeverbeke, JolienKatholieke Univ Leuven, Lab Cognit Neurol, B-3000 Louvain, Belgium.;Katholieke Univ Leuven, Leuven Inst Neurosci & Dis, Alzheimer Res Ctr, B-3000 Louvain, Belgium.
(författare)
-
Vanderstichele, Hugo M. J.ADx NeuroSci, B-9052 Ghent, Belgium.
(författare)
-
Lilja, JohanUppsala universitet,Radiologi,GE Healthcare, S-75125 Uppsala, Sweden.(Swepub:uu)johli248
(författare)
-
Nelissen, NatalieKatholieke Univ Leuven, Lab Cognit Neurol, B-3000 Louvain, Belgium.;Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England.
(författare)
-
Van Laere, KoenKatholieke Univ Leuven, Leuven Inst Neurosci & Dis, Alzheimer Res Ctr, B-3000 Louvain, Belgium.;Katholieke Univ Leuven, Nucl Med & Mol Imaging Dept, B-3000 Louvain, Belgium.;Katholieke Univ Leuven Hosp, B-3000 Louvain, Belgium.
(författare)
-
Dupont, PatrickKatholieke Univ Leuven, Lab Cognit Neurol, B-3000 Louvain, Belgium.;Katholieke Univ Leuven, Leuven Inst Neurosci & Dis, Alzheimer Res Ctr, B-3000 Louvain, Belgium.
(författare)
-
Hilven, KellyKatholieke Univ Leuven, Lab Neuroimmunol, B-3000 Louvain, Belgium.
(författare)
-
Poesen, KoenKatholieke Univ Leuven, Lab Mol Neurobiomarker Res, B-3000 Louvain, Belgium.;UZ Leuven, Lab Med, B-3000 Louvain, Belgium.
(författare)
-
Vandenberghe, RikKatholieke Univ Leuven, Lab Cognit Neurol, B-3000 Louvain, Belgium.;Katholieke Univ Leuven, Leuven Inst Neurosci & Dis, Alzheimer Res Ctr, B-3000 Louvain, Belgium.;Univ Hosp Leuven, Dept Neurol, B-3000 Louvain, Belgium.
(författare)
-
Katholieke Univ Leuven, Lab Cognit Neurol, B-3000 Louvain, Belgium.;Katholieke Univ Leuven, Leuven Inst Neurosci & Dis, Alzheimer Res Ctr, B-3000 Louvain, Belgium.ADx NeuroSci, B-9052 Ghent, Belgium.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Alzheimer's Research & Therapy: Springer Science and Business Media LLC71758-9193
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Adamczuk, Katarz ...
-
Schaeverbeke, Jo ...
-
Vanderstichele, ...
-
Lilja, Johan
-
Nelissen, Natali ...
-
Van Laere, Koen
-
visa fler...
-
Dupont, Patrick
-
Hilven, Kelly
-
Poesen, Koen
-
Vandenberghe, Ri ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Neurologi
- Artiklar i publikationen
-
Alzheimer's Rese ...
- Av lärosätet
-
Uppsala universitet